Skyder Pharma Private Limited - Company Profile

It is a business services private limited company based in Jaipur, Rajasthan, India, established in 2018.
2018 Jaipur, Rajasthan, India Active
Last Updated:
Access Report
About Skyder Pharma Private Limited

Skyder Pharma Private Limited, a active private limited company, was established on 16 February 2018 in Jaipur, Rajasthan, India. Engaging in other services within the business services sector, it holds CIN: U74999RJ2018PTC060247. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Rajesh Purohit (Director), Rakesh Kumar (Director). Past directors included Anup Saxena, Raj Singh, Anju Jaura. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at P.No. 21/72, Bhrighu Path, Mansarovar,, Jaipur, Rajasthan, 302020.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999RJ2018PTC060247

  • Registration Number

    060247

  • Incorporation Date

    16 February 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 8 Year, 4 Months
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth **** -61.64%
  • Profit Growth **** -213.31%
  • Ebitda **** -29.23%
  • Net Worth -303.23%
  • Total Assets -24.53%
Company report

Skyder Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Skyder Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Skyder Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajesh Purohit Director 21 Jun 2018 Current
Rakesh Kumar Director 16 Feb 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Mar 2019 Past
Pramod Abcsdd Additional Director 27 Mar 2019 Past
Pramod Abcsdd Additional Director 27 Mar 2019 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 21 Jun 2018 Past
Pramod Abcsdd Director 28 Apr 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Skyder Pharma.

Skyder Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 61.64% decrease. The company also saw a substantial fall in profitability, with a 213.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 303.23%.

Skyder Pharma revenue growth over time
Skyder Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -61.64%
*******
*******
*******
*******
Revenue from Operations
*******
 -61.61%
*******
*******
*******
*******
Total Assets
*******
 -24.53%
*******
*******
*******
*******
Profit or Loss
*******
 -213.31%
*******
*******
*******
*******
Net Worth
*******
 -303.23%
*******
*******
*******
*******
EBITDA
*******
 -29.23%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Skyder Pharma?

Unlock access to Skyder Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Skyder Pharma?

Unlock and access historical data on people associated with Skyder Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Skyder Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skyder Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Skyder Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Skyder Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Skyder Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Jaipur. was recorded as a recent event.

  • Director Appointment

    Progress on Rajesh Purohit was appointed as a Director was appointed as a Director on 21 Jun 2018 & has been associated with this company since 8 years 14 days . was documented.

  • Director Appointment

    Progress on Rakesh Kumar was appointed as a Director was appointed as a Director on 16 Feb 2018 & has been associated with this company since 8 years 4 months . was documented.

  • Company Incorporation

    The activity Skyder Pharma Private Limited was registered on 16 Feb 2018 with Roc Jaipur & aged 8 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Skyder Pharma Private Limited?

The CIN of Skyder Pharma Private Limited is U74999RJ2018PTC060247.

Where is Skyder Pharma Private Limited headquartered?

Skyder Pharma Private Limited is headquartered at P.No. 21/72, Bhrighu Path, Mansarovar,, Jaipur, Rajasthan, 302020.

When was Skyder Pharma Private Limited incorporated?

Skyder Pharma Private Limited was incorporated on 16 February 2018.

Who are the current directors of Skyder Pharma Private Limited?

The current directors of Skyder Pharma Private Limited are

What is the primary industry of Skyder Pharma Private Limited?

The primary industry of Skyder Pharma Private Limited is Business Services.

Is Skyder Pharma Private Limited a listed company?

Skyder Pharma Private Limited is unlisted.

What is the capital structure of Skyder Pharma Private Limited?

The authorized capital of Skyder Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available